Yohimbine's anxiogenic action: Evidence for noradrenergic and dopaminergic sites
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 32 (1) , 151-156
- https://doi.org/10.1016/0091-3057(89)90225-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the ratJournal of Pharmacy and Pharmacology, 1987
- The contribution of behavioural studies to the neuropharmacology of anxietyNeuropharmacology, 1987
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984
- Pre-junctional α2-adrenoceptor activity of B-HT920Journal of Pharmacy and Pharmacology, 1983
- Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidineLife Sciences, 1983
- Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: Evidence for antidopaminergic properties of some alpha antagonistsCellular and Molecular Life Sciences, 1982
- Evidence that LY-141865 specifically stimulates the D-2 dopamine receptorNature, 1981
- Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the ?Clonidine-type?Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
- Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brainEuropean Journal of Pharmacology, 1976
- The effect of yohimbine on the turnover of brain catecholamines and serotoninEuropean Journal of Pharmacology, 1975